Berry Genomics Co.,Ltd
Berry Genomics Co., Ltd., headquartered in China, is a leading player in the genomics industry, specialising in advanced genetic testing and precision medicine. Founded in 2010, the company has rapidly established itself as a pioneer in the field, with significant operational presence across Asia and beyond. The firm offers a range of innovative products and services, including non-invasive prenatal testing (NIPT) and comprehensive genomic profiling, which are distinguished by their accuracy and reliability. Berry Genomics is committed to enhancing healthcare through cutting-edge technology and has achieved notable milestones, such as extensive partnerships with healthcare institutions and a strong market position in genetic diagnostics. With a focus on research and development, Berry Genomics continues to drive advancements in genomics, making significant contributions to personalised medicine and improving patient outcomes.
DitchCarbon Score
How does Berry Genomics Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Berry Genomics Co.,Ltd's score of 15 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Berry Genomics Co.,Ltd's reported carbon emissions
Berry Genomics Co., Ltd, headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not outlined any formal reduction targets or climate pledges, which limits the ability to assess their commitments towards climate action. In the absence of specific emissions data or reduction initiatives, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and carbon neutrality. As industry standards evolve, Berry Genomics may consider establishing measurable climate commitments in the future to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Berry Genomics Co.,Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
